BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gu L, Ren F, Fang X, Yuan L, Liu G, Wang S. Exosomal MicroRNA-181a Derived From Mesenchymal Stem Cells Improves Gut Microbiota Composition, Barrier Function, and Inflammatory Status in an Experimental Colitis Model. Front Med (Lausanne) 2021;8:660614. [PMID: 34249964 DOI: 10.3389/fmed.2021.660614] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Lin L, Zhang K, Xiong Q, Zhang J, Cai B, Huang Z, Yang B, Wei B, Chen J, Niu Q. Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression. J Autoimmun 2023;:103001. [PMID: 36931952 DOI: 10.1016/j.jaut.2023.103001] [Reference Citation Analysis]
2 Qian W, Huang L, Xu Y, Lu W, Wen W, Guo Z, Zhu W, Li Y. Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis. Inflamm Bowel Dis 2022:izac225. [PMID: 36287066 DOI: 10.1093/ibd/izac225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chang Y, Zhang Y, Jiang Y, Zhao L, Lv C, Huang Q, Guan J, Jin S, Rehman MU. From Hair to Colon: Hair Follicle-Derived MSCs Alleviate Pyroptosis in DSS-Induced Ulcerative Colitis by Releasing Exosomes in a Paracrine Manner. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/9097530] [Reference Citation Analysis]
4 Yan X, Yao J, Li Y, Zhang W, Xi M, Chen M, Li Y. Global trends in research on miRNA–microbiome interaction from 2011 to 2021: A bibliometric analysis. Front Pharmacol 2022;13:974741. [DOI: 10.3389/fphar.2022.974741] [Reference Citation Analysis]
5 Li M, Wang F, Zhang C, Li MA, Wang T, Li YC, Fu FH. Integrated systematic pharmacology analysis and experimental validation to reveal the mechanism of action of Semen aesculi on inflammatory bowel diseases. J Ethnopharmacol 2022;298:115627. [PMID: 35985613 DOI: 10.1016/j.jep.2022.115627] [Reference Citation Analysis]
6 Eiro N, Fraile M, González-jubete A, González LO, Vizoso FJ. Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges. IJMS 2022;23:8905. [DOI: 10.3390/ijms23168905] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yu S, Sun Y, Shao X, Zhou Y, Yu Y, Kuai X, Zhou C. Leaky Gut in IBD: Intestinal Barrier-Gut Microbiota Interaction. J Microbiol Biotechnol 2022;32:825-34. [PMID: 35791076 DOI: 10.4014/jmb.2203.03022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Vieujean S, Caron B, Haghnejad V, Jouzeau JY, Netter P, Heba AC, Ndiaye NC, Moulin D, Barreto G, Danese S, Peyrin-Biroulet L. Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. Int J Mol Sci 2022;23:7611. [PMID: 35886959 DOI: 10.3390/ijms23147611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Huldani H, Margiana R, Ahmad F, Opulencia MJC, Ansari MJ, Bokov DO, Abdullaeva NN, Siahmansouri H. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. International Immunopharmacology 2022;107:108698. [DOI: 10.1016/j.intimp.2022.108698] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Vitulo M, Gnodi E, Meneveri R, Barisani D. Interactions between Nanoparticles and Intestine. IJMS 2022;23:4339. [DOI: 10.3390/ijms23084339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tian Y, Cheng C, Wei Y, Yang F, Li G. The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation. Cells 2022;11:1005. [DOI: 10.3390/cells11061005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhao X, Cui D, Yuan W, Chen C, Liu Q. Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis. Bioengineered 2022;13:7392-409. [PMID: 35259053 DOI: 10.1080/21655979.2022.2047405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Tsigalou C, Konstantinidis T, Aloizou A, Bezirtzoglou E, Tsakris A. Future Therapeutic Prospects in Dealing with Autoimmune Diseases: Treatment Based on the Microbiome Model. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_25] [Reference Citation Analysis]
14 Liu C, Bayado N, He D, Li J, Chen H, Li L, Li J, Long X, Du T, Tang J, Dang Y, Fan Z, Wang L, Yang PC. Therapeutic Applications of Extracellular Vesicles for Myocardial Repair. Front Cardiovasc Med 2021;8:758050. [PMID: 34957249 DOI: 10.3389/fcvm.2021.758050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
15 Wang Q, Liu Y, Kuang S, Li R, Weng N, Zhou Z. miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9. Evid Based Complement Alternat Med 2021;2021:1303375. [PMID: 34925522 DOI: 10.1155/2021/1303375] [Reference Citation Analysis]
16 Pan Q, Guo F, Huang Y, Li A, Chen S, Chen J, Liu HF, Pan Q. Gut Microbiota Dysbiosis in Systemic Lupus Erythematosus: Novel Insights into Mechanisms and Promising Therapeutic Strategies. Front Immunol 2021;12:799788. [PMID: 34925385 DOI: 10.3389/fimmu.2021.799788] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]